An estimated 20 million Americans have some form of thyroid disease.1 During January, recognized as Thyroid Awareness Month, YARAL Pharma is raising awareness of thyroid disease, particularly hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. Despite its prevalence, thyroid disease remains widely misunderstood, with many people unaware of its signs and symptoms. Read More >
YARAL Pharma Inc. is the U.S. subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they’re cared for, YARAL Pharma is proud to offer the same values and expertise of its parent company to the US market. Dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes, YARAL Pharma offers its customers high-quality products across a range of therapeutic areas, continuity of supply, and a commitment to exceptional customer service.
This post is related to:
